Report Summary
Summary
Currently, there are no standard leukemia screening methods recommended for regularly testing the leukemia affected patients. Specifically, no leukemia screening test has been reliably confirmed enough to detect the cancer in its early stages before the development of symptoms. Research and development for the leukemia screening is going on, and there is still much to be known about the exact causes of leukemia. As the understanding continues to increase, scientists are gaining a greater knowledge of possible ways to prevent, screen and treat this condition.
Leukemia is commonly caused because of the exposure to radiations, changing lifestyle, genetic mutations, and environmental conditions. Leukemia cases are more commonly found in adults and are observed to develop with aging. Thus, increasing aging population and high occurrence of leukemia are the factors rising the leukemia screening market. Also, novel advancements and R&D in the oncology sector and growing number of biotechnology companies, may also expected to boost the market growth.
Globally, North America has a prominent leukemia screening market followed by Europe because of increasing awareness in patients, technological advancements, supportive regulatory regulations and a sorted healthcare infrastructure. The market in Asia Pacific is expected to grow due to the prevalence of unmet needs. Improving healthcare infrastructure and increase in the R&D investments will promote the leukemia screening market in Asia Pacific. Middle East Africa and Latin America leukemia screening market are projected to grow significantly due to rising disposable income and increasing prevalence of leukemia.
In 2020, the global Leukemia Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Leukemia Screening market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Abbott
Abbvie
GE Healthcare
Siemens Healthcare
Philips Healthcare
Toshiba Medical Systems
Hitachi Medical Systems
Varian Medical Systems
Shimadzu Corporation
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Bone Marrow Aspiration and Biopsy
Chest X-Ray or Chest CAT Scan
Spinal Tap
Market segment by Application, the market can be split into
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals
The study objectives of this report are:
To study and forecast the market size of Leukemia Screening in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Leukemia Screening are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Leukemia Screening market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
Leukemia Screening Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Leukemia Screening
1.1 Leukemia Screening Market Overview
1.1.1 Leukemia Screening Product Scope
1.1.2 Market Status and Outlook
1.2 Global Leukemia Screening Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Leukemia Screening Market by Type
1.3.1 Bone Marrow Aspiration and Biopsy
1.3.2 Chest X-Ray or Chest CAT Scan
1.3.3 Spinal Tap
1.4 Leukemia Screening Market by End Users/Application
1.4.1 Cancer Research Centers
1.4.2 Diagnostic Laboratories
1.4.3 Clinics
1.4.4 Hospitals
2 Global Leukemia Screening Competition Analysis by Players
2.1 Leukemia Screening Market Size (Value) by Players (2019 and 2020)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbott
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Leukemia Screening Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Abbvie
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Leukemia Screening Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 GE Healthcare
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Leukemia Screening Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Siemens Healthcare
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Leukemia Screening Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Philips Healthcare
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Leukemia Screening Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Toshiba Medical Systems
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Leukemia Screening Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Hitachi Medical Systems
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Leukemia Screening Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Varian Medical Systems
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Leukemia Screening Revenue (Value) (2017-2020)
3.8.5 Recent Developments
3.9 Shimadzu Corporation
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Leukemia Screening Revenue (Value) (2017-2020)
3.9.5 Recent Developments
4 Global Leukemia Screening Market Size by Type and Application (2017-2020)
4.1 Global Leukemia Screening Market Size by Type (2017-2020)
4.2 Global Leukemia Screening Market Size by Application (2017-2020)
4.3 Potential Application of Leukemia Screening in Future
4.4 Top Consumer/End Users of Leukemia Screening
5 North America Leukemia Screening Development Status and Outlook
5.1 North America Leukemia Screening Market Size (2017-2020)
5.2 North America Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
6 Europe Leukemia Screening Development Status and Outlook
6.1 Europe Leukemia Screening Market Size (2017-2020)
6.2 Europe Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
7 China Leukemia Screening Development Status and Outlook
7.1 China Leukemia Screening Market Size (2017-2020)
7.2 China Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
8 Rest of Asia Pacific Leukemia Screening Development Status and Outlook
8.1 Rest of Asia Pacific Leukemia Screening Market Size (2017-2020)
8.2 Rest of Asia Pacific Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
9 Central & South America Leukemia Screening Development Status and Outlook
9.1 Central & South America Leukemia Screening Market Size (2017-2020)
9.2 Central & South America Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
10 Middle East & Africa Leukemia Screening Development Status and Outlook
10.1 Middle East & Africa Leukemia Screening Market Size (2017-2020)
10.2 Middle East & Africa Leukemia Screening Market Size and Market Share by Players (2019 and 2020)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Leukemia Screening Market Size (Value) by Regions (2021-2027)
11.1.1 North America Leukemia Screening Revenue and Growth Rate (2021-2027)
11.1.2 Europe Leukemia Screening Revenue and Growth Rate (2021-2027)
11.1.3 China Leukemia Screening Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Leukemia Screening Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Leukemia Screening Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Leukemia Screening Revenue and Growth Rate (2021-2027)
11.2 Global Leukemia Screening Market Size (Value) by Type (2021-2027)
11.3 Global Leukemia Screening Market Size by Application (2021-2027)
12 Leukemia Screening Market Dynamics
12.1 Leukemia Screening Market Opportunities
12.2 Leukemia Screening Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Leukemia Screening Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Leukemia Screening Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
